Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience [Phase 4]

View source ↗

Summary

A Phase 4 study evaluated adding enfuvirtide to ongoing HAART in HIV patients with prior treatment experience to assess safety and efficacy; results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Enfuvirtide (Fuzeon) (enfuvirtide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2011-09-02